Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus Combined With ATRA for Autoimmune Anemia
NCT04324411Phase 4Withdrawn
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sirolimus and tretinoin in Autoimmune Hemolytic Anemia (AIHA), sponsored by Peking Union Medical College Hospital. Primary endpoints: Overall Response Rate at 1 year and Rate of side effects at 1 year. Planned start Apr 2020; status: withdrawn.
02
Drugs
sirolimustretinoin
03
Conditions
Autoimmune Hemolytic Anemia (AIHA)
Beyond the preview
Go deeper on NCT04324411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04324411.